David Potter, MD, PhD
David A. Potter, M.D., Ph.D. is a Medical Oncologist at the Masonic Cancer Center University of Minnesota and Professor of Medicine in the Hematology, Oncology, and Transplantation Division. He works on the development of therapies that target cytochrome P450 enzymes in breast cancer. He also works on the conduct of Phase 1 clinical trials in the PRE I-SPY Phase I consortium.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GileadDate added:08/03/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:ImmunoMet TherapeuticsDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:PfizerDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Nektar TherapeuticsDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:TakedaDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Seattle GeneticsDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Innocrin PharmaceuticalsDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:AstraZenecaDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:AbbVieDate added:08/23/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:GileadDate added:08/23/2023